Cedrik Britten und Glaxosmithkline - Info zur Person

(1 - 15 von 16

)

Immatics veröffentlicht Ergebnisse des zweiten Quartals sowie...

www.boerse.de

· Juni wurde Dr. Cedrik Britten zum Chief Medical Officer (CMO) von Immatics benannt. Zuvor war Dr. Britten als Vice President und Head of Oncology Cell Therapy Research Unit bei GlaxoSmithKline plc ...

Immatics Announces Second Quarter Financial Results and Business...

www.wallstreet-online.de

· On June 1, Cedrik Britten, MD, joined Immatics as Chief Medical Officer (CMO). Dr. Britten previously served as Vice President and Head of Oncology Cell Therapy Research Unit at GlaxoSmithKline ...

Conference Forum's Immuno-Oncology 360° Announces the Support of Key...

www.prweb.com

... MD, Clinical Team Leader, Thoracic and Head/Neck Oncology, FDA, CDER, FDA; Cedrik Britten, MD, Head of Cell Therapy, GlaxoSmithKline ...

3rd Annual Advances in Immuno-Oncology Congress | AllCongress

www.allcongress.com

Cedrik Britten, VP, Head of Oncology Cell Therapy DPU, Oncology R&D. GlaxoSmithKline. Regina Heidenreich, Head of Immunotherapy. CureVac GmbH. Guillaume Vignon, Global Head of Immuno-Oncology Licensing & Business Development. Merck KGaA. David Krige, Head of Biomarkers. Immunocore ...

| Nature Careers

www.nature.com

Celyad. - Alex Bloom, Director, Global Regulatory Affairs CellMedica. - Cedrik Britten, Vice President & Head of Oncology Cell Therapy DPU GlaxoSmithKline.

Cedrik M. Britten | Longdom Publishing SL

www.longdom.org

Cedrik M. Britten,GlaxoSmithKline Deutschland,Immunome Research.

CONFERENCE PROGRAM AND SCHEDULE - PDF Free Download

docplayer.net

CONFERENCE PROGRAM AND SCHEDULE Wednesday, September 16, ... Cedrik Britten, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom Lunch will be …

HUM-MOLGEN events: 3rd Annual Cell & Gene Therapy Congress

hum-molgen.org

Cedrik Britten, Vice President & Head of Oncology Cell Therapy DPU GlaxoSmithKline. Markwin Velders, Vice President, Operations Kite Pharma. Gwendolyn Binder-Scholl, Chief Technology Officer Adaptimmune. Ajan Reginald, Executive Director & Co-founder Cell Therapy Ltd. Sylvain Arnould, Process Development & Production Director Celyad. Alex Bloom, Director, Global Regulatory Affairs …